Elevated plasma prolactin in abstinent methamphetamine-dependent subjects

REFERENCES

• Uhart M, Wand GS. Stress, alcohol and drug interaction: an update of human research. Addict Biol 2009; 14(1):43–64.
   PubMed Web of Science ®Google Scholar
• Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 2008; 1141:105–130.
   PubMed Web of Science ®Google Scholar
• Durham RA, Eaton MJ, Moore KE, Lookingland KJ. Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons. Eur J Pharmacol 1997; 335(1):37–42.
   PubMed Web of Science ®Google Scholar
• Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80(4):1523–1631.
   PubMed Web of Science ®Google Scholar
• Pilotte NS, Sharpe LG, Dax EM. Multiple, but not acute, infusions of cocaine alter the release of prolactin in male rats. Brain Res 1990; 512(1):107–112.
   PubMed Web of Science ®Google Scholar
• Mello NK, Mendelson JH. Cocaine’s effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 1997; 57(3):571–599.
   PubMed Web of Science ®Google Scholar
• Contoreggi C, Herning RI, Koeppl B, Simpson PM, Negro PJ, Jr, Fortner-Burton C, Hess J. Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion. Neuroendocrinology 2003; 78(3):154–162.
   PubMed Web of Science ®Google Scholar
• Patkar AA, Mannelli P, Certa KM, Peindl K, Murray H, Vergare MJ, Berrettini WH. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. Psychopharmacology (Berl) 2004; 176(1): 74–81.
   PubMed Web of Science ®Google Scholar
• Farré M, de la Torre R, González ML, Terán MT, Roset PN, Menoyo E, Camí J. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 1997; 283(1):164–176.
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Teoh SK, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry 1988; 145(9):1094–1098.
   PubMed Web of Science ®Google Scholar
• Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 2009; 29(47):14734–14740.
   PubMed Web of Science ®Google Scholar
• Neto LV, Machado Ede O, Luque RM, Taboada GF, Marcondes JB, Chimelli LM, Quintella LP, Niemeyer P, Jr, de Carvalho DP, Kineman RD, Gadelha MR. Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly. J Clin Endocrinol Metab 2009; 94(6):1931–1937.
   PubMed Web of Science ®Google Scholar
• Moresco RM, Cavallaro R, Messa C, Bravi D, Gobbo C, Galli L, Lucignani G, Colombo C, Rizzo G, Velonà I, Smeraldi E, Fazio F. Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine. J Psychopharmacol 2004; 18(3):355–365.
   PubMed Web of Science ®Google Scholar
• Logan J, Fowler JS, Volkow ND, Wang G-J, Ding Y-S, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16:834–840.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 2005; 29(7):1351–1355.
   PubMed Web of Science ®Google Scholar
• Lovallo WR. Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 2006; 59(3):195–202.
   PubMed Web of Science ®Google Scholar
• Li SX, Li J, Epstein DH, Zhang XY, Kosten TR, Lu L. Serum cortisol secretion during heroin abstinence is elevated only nocturnally. Am J Drug Alcohol Abuse 2008; 34(3):321–328.
   PubMed Web of Science ®Google Scholar
• Mello NK, Mendelson JH. Cocaine’s effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 1997; 57(3):571–599.
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H. Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacology (Berl) 1999; 142(1):41–50.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158(12):2015–2021.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21(23):9414–9418.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Zhu BL, Miyaishi S, Ishizu H, Maeda H. Increase in clusterin-containing follicles in the adenohypophysis of drug abusers. Int J Legal Med 2007; 121(5):395–402.
   PubMed Web of Science ®Google Scholar
• Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic-induced hyperprolactinemia. Pharmacotherapy 2009; 29(1):64–73.
   PubMed Web of Science ®Google Scholar
• Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004; 13(3):248–255.
   PubMed Web of Science ®Google Scholar
• McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100(9): 1320–1329.
   PubMed Web of Science ®Google Scholar